z-logo
Premium
COMPARISON OF CHEMOTHERAPY RESPONSE AND ADVERSE EFFECTS OF DOUBLE‐PLATINUM PLUS EGFR‐TKI VERSUS DOUBLE‐PLATINUM ALONE ON PATIENTS WITH NSCLC WHO HAD DISEASE PROGRESSION FOLLOWING EGFR‐TKI TREATMENT
Publication year - 2017
Publication title -
respirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 85
eISSN - 1440-1843
pISSN - 1323-7799
DOI - 10.1111/resp.13207_83
Subject(s) - medicine , oncology , chemotherapy , adverse effect , platinum , disease , biochemistry , chemistry , catalysis

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom